Rankings
▼
Calendar
OCGN FY 2014 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena
OCGN
Ocugen, Inc.
$754M
FY 2014 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$33M
Net Income
-$23M
EPS (Diluted)
$-891.47
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$22M
Stock-Based Comp.
$547,000
Balance Sheet
Total Assets
$65M
Total Liabilities
$11M
Stockholders' Equity
$54M
Cash & Equivalents
$58M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$8,000
-100.0%
Gross Profit
$0
$8,000
-100.0%
Operating Income
-$33M
-$17M
-93.9%
Net Income
-$23M
-$26M
+11.4%
← FY 2013
All Quarters
FY 2015 →